Vaccination against Lyme Disease with recombinant Borrelia burgdorferi outer-surface protein A (rOspA) in horses

Vaccine

Volumn 18, Issue 5-6, 1999, Pages 540-548

  Chang, Yung Fu ^a   Novosol, Vesna ^a   McDonough, Sean P ^a   Chang, Chao Fu ^a   Jacobson, Richard H ^a   Divers, Thomas ^a   Quimby, Fred W ^a   Shin, Sang ^a   Lein, Donald H ^a  

^a Department of Obstetrics Gynecology   (United States)

Author keywords

Aluminium hydroxide; Borrelia burgdorferi; Equine; Immunogenicity; Lyme borreliosis; OspA

Indexed keywords

ADJUVANT; ALUMINUM OXIDE; OUTER MEMBRANE PROTEIN; PROTEIN A; RECOMBINANT PROTEIN;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BORRELIA BURGDORFERI; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HORSE; INTRAMUSCULAR DRUG ADMINISTRATION; LYME DISEASE; LYMPH NODE; NONHUMAN; PRIORITY JOURNAL; SKIN BIOPSY; VACCINATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL OUTER MEMBRANE PROTEINS; BACTERIAL VACCINES; BORRELIA BURGDORFERI GROUP; HORSE DISEASES; HORSES; LIPOPROTEINS; LYME DISEASE; RECOMBINANT PROTEINS; VACCINATION; VACCINES, SYNTHETIC;

EID: 0032849096     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00187-5     Document Type: Article

References (50)

1. Browning A., Carter S.D., Barnes A., May C., Bennett D. Lameness associated with Borrelia burgdorferi infection in the horse. Vet. Rec. 132:1993;610-611.
2. Burgess E.C., Mattison M. Encephalitis associated with Borrelia burgdorferi infection in a horse. J. Am. Vet. Med. Assoc. 191:1987;1457-1458.
3. Cohen D., Bosler E.M., Bernard W., Meirs Dd., Eisner R., Schulze T.L. Epidemiologic studies of Lyme disease in horses and their public health significance. Ann. NY Acad. Sci. 539:1988;244-257.
4. Kornblatt A.N., Urband P.H., Steere A.C. Arthritis caused by Borrelia burgdorferi in dogs. J. Am. Vet. Med. Assoc. 186:1985;960-964.
5. Lissman B.A., Bosler E.M., Camay H., Ormiston B.G., Benach J.L. Spirochete-associated arthritis (Lyme disease) in a dog. J. Am. Vet. Med. Assoc. 185:1984;219-220.
6. Magnarelli L.A., Anderson J.F., Levine H.R., Levy S.A. Tick parasitism and antibodies to Borrelia burgdorferi in cats. J. Am. Vet. Med. Assoc. 197:1990;63-66.
7. Parker J.L., White K.K. Lyme borreliosis in cattle and horses: a review of the literature. Cornell Vet. 82:1992;253-274.
8. Chang Y-F, Novosol V, McDonough SP, Chang C-F, Jacobson RH, Divers T, Quimby FW, Shin S, Lein DH. Experimental infection of ponies with Borrelia burgdorferi by exposure to Ixodid ticks. Vet Pathol, submitted for publication.
9. Chang Y.F., Appel M.J., Jacobson R.H., Shin S.J., Harpending P., Straubinger R., Patrican L.A., Mohammed H., Summers B.A. Recombinant OspA protects dogs against infection and disease caused by Borrelia burgdorferi. Infect. Immun. 63:1995;3543-3549.
10. Sigal L.H., Zahradnik J.M., Lavin P., Patella S.J., Bryant G., Haselby R., Hilton E., Kunkel M., Adler-Klein D., Doherty T., Evans J., Molloy P.J., Seidner A.L., Sabetta J.R., Simon H.J., Klempner M.S., Mays J., Marks D., Malawista S.E. A vaccine consisting of recombinant Borrelia burgdorferi outer-surface protein A to prevent Lyme disease. N. Engl. J. Med. 339:1998;216-222. (erratum: N Engl J Med 1998; 339(8): 571).
11. Wormser G.P., Nowakowski J., Nadelman R.B., Schwartz I., McKenna D., Holmgren D., Aguero-Rosenfeld M. Efficacy of an OspA vaccine preparation for prevention of Lyme disease in New York State. Infection. 26:1998;208-212.
12. Philipp M.T., Lobet Y., Bohm R.P. Jr., Roberts E.D., Dennis V.A., Gu Y., Lowrie R.C. Jr, Desmons P., Duray P.H., England J.D., Hauser P., Piesman J., Xu K. The outer surface protein A (OspA) vaccine against Lyme disease: efficacy in the rhesus monkey. Vaccine. 15:1997;1872-1887.
13. Kurtenbach K., Dizij A., Voet P., Hauser P., Simon M.M. Vaccination of natural reservoir hosts with recombinant lipidated OspA induces a transmission-blocking immunity against Lyme disease spirochaetes associated with high levels of LA-2 equivalent antibodies. Vaccine. 15:1997;1670-1674.
14. Gern L., Hu C.M., Voet P., Hauser P., Lobet Y. Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii. Vaccine. 15:1997;1551-1557.
15. Fikrig E., Barthold S.W., Kantor F.S., Flavell R.A. Protection of mice against the Lyme disease agent by immunizing with recombinant OspA. Science. 250:1990;553-556.
16. Fikrig E., Telford S.R. 3rd, Wallich R., Chen M., Lobet Y., Matuschka F.R., Kimsey R.B., Kantor F.S., Barthold S.W., Spielman A. Vaccination against Lyme disease caused by diverse Borrelia burgdorferi. J. Exp. Med. 181:1995;215-221.
17. Ma J., Hine P.M., Clough E.R., Fish D., Coughlin R.T., Beltz G.A., Shew M.G. Safety, efficacy, and immunogenicity of a recombinant Osp subunit canine Lyme disease vaccine. Vaccine. 14:1996;1366-1374.
18. Chang Y.-F., Lauderdale T.-L., Lee W.Y., Shin S.J., Jacobson R.H., Appel M.J., Lein D.H. Expression and secretion of outer surface protein (Osp-A) of Borrelia burgdorferi from Escherichia coli. FEMS Microbiol. Lett. 109:1992;297-302.
19. Appel M.J., Allan S., Jacobson R.H., Lauderdale T.L., Chang Y.F., Shin S.J., Thomford J.W., Todhunter R.J., Summers B.A. Experimental Lyme disease in dogs produces arthritis and persistent infection. J. Infect. Dis. 167:1993;651-664.
20. Shin S.J., Chang Y.F., Jacobson R.H., Shaw E., Lauderdale T.L., Appel M.J., Lein D.H. Cross-reactivity between B. burgdorferi and other spirochetes affects specificity of serotests for detection of antibodies to the Lyme disease agent in dogs. Vet. Microbiol. 36:1993;161-174.
21. Jacobson R.H., Chang Y.F., Shin S.J. Lyme disease: laboratory diagnosis of infected and vaccinated symptomatic dogs. Semin. Vet. Med. Surg. 11:1996;172-182.
22. Straubinger R.K., Chang Y.F., Jacobson R.H., Appel M.J. Sera from OspA-vaccinated dogs, but not those from tick-infected dogs, inhibit in vitro growth of Borrelia burgdorferi. J. Clin. Microbiol. 33:1995;2745-2751.
23. Clark J.R., Carlson R.D., Sasaki C.T., Pachner A.R., Steere A.C. Facial paralysis in Lyme disease. Laryngoscope. 95:1985;1341-1345.
24. Nowling J.M., Phillipp M.T. Killing of Borrelia burgdorferi by antibody elicited by OspA vaccine is inefficient in the absence of complement. Infect. Immun. 67:1999;443-445.
25. Fikrig E., Telford S.Rd., Barthold S.W., Kantor F.S., Spielman A., Flavell R.A. Elimination of Borrelia burgdorferi from vector ticks feeding on OspA-immunized mice. Proc. Natl. Acad. Sci. USA. 89:1992;5418-5421.
26. Baranton G., Postic D., Saint Girons I., Boerlin P., Piffaretti J.C., Assous M., Grimont P.A. Delineation of Borrelia burgdorferi sensu stricto, Borrelia garinii sp. nov., and group VS461 associated with Lyme borreliosis. Int. J. Syst. Bacteriol. 42:1992;378-383.
27. Dykhuizen D.E., Polin D.S., Dunn J.J., Wilske B., Preac-Mursic V., Dattwyler R.J., Luft B.J. Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development. Proc. Natl. Acad. Sci. USA. 90:1993;10163-10167.
28. Peter O., Bretz A.G., Bee D. Occurrence of different genospecies of Borrelia burgdorferi sensu lato in ixodid ticks of Valais, Switzerland. Eur. J. Epidemiol. 11:1995;463-467.
29. Wilske B., Preac-Mursic V., Gobel U.B., Graf B., Jauris S., Soutschek E., Schwab E., Zumstein G. An OspA serotyping system for Borrelia burgdorferi based on reactivity with monoclonal antibodies and OspA sequence analysis. J. Clin. Microbiol. 31:1993;340-350.
30. Golde W.T., Burkot T.R., Piesman J., Dolan M.C., Capiau C., Hauser P., Dequesne G., Lobet Y. The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi. Vaccine. 13:1995;435-441.
31. Gern L., Rais O., Capiau C., Hauser P., Lobet Y., Simoen E., Voet P., Petre J. Immunization of mice by recombinant OspA preparations and protection against Borrelia burgdorferi infection induced by Ixodes ricinus tick bites. Immunol. Lett. 39:1994;249-258.
32. Keller D., Koster F.T., Marks D.H., Hosbach P., Erdile L.F., Mays J.P. Safety and immunogenicity of a recombinant outer surface protein A Lyme vaccine. JAMA. 271:1994;1764-1768.
33. Fikrig E., Barthold S.W., Kantor F.S., Flavell R.A. Protection of mice from Lyme borreliosis by oral vaccination with Escherichia coli expressing OspA. J. Infect. Dis. 164:1991;1224-1227.
34. Fikrig E., Barthold S.W., Flavell R.A. OspA vaccination of mice with established Borrelia burgdorferi infection alters disease but not infection. Infect. Immun. 61:1993;2553-2557.
35. Schaible U.E., Wallich R., Kramer M.D., Gern L., Anderson J.F., Museteanu C., Simon M.M. Immune sera to individual Borrelia burgdorferi isolates or recombinant OspA thereof protect SCID mice against infection with homologous strains but only partially or not at all against those of different OspA/OspB genotype. Vaccine. 11:1993;1049-1054.
36. Walker D.H., Barbour A.G., Oliver J.H., Lane R.S., Dumler J.S., Dennis D.T., Persing D.H., Azad A.F., McSweegan E. Emerging bacterial zoonotic and vector-borne diseases. Ecological and epidemiological factors. JAMA. 275:1996;463-469.
37. Dumler J.S., Bakken J.S. Ehrlichial diseases of humans: emerging tick-borne infections. Clin. Infect. Dis. 20:1995;1102-1110.
38. Magnarelli L.A., Dumler J.S., Anderson J.F., Johnson R.C., Fikrig E. Coexistence of antibodies to tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in human sera. J. Clin. Microbiol. 33:1995;3054-3057.
39. Magnarelli L.A., Anderson J.F., Stafford K.C. 3rd, Dumler J.S. Antibodies to multiple tick-borne pathogens of babesiosis, ehrlichiosis, and Lyme borreliosis in white-footed mice. J. Wildl. Dis. 33:1997;466-473.
40. Mitchell P.D., Reed K.D., Hofkes J.M. Immunoserologic evidence of coinfection with Borrelia burgdorferi, Babesia microti, and human granulocytic Ehrlichia species in residents of Wisconsin and Minnesota. J. Clin. Microbiol. 34:1996;724-727.
41. Telford S.R. 3rd, Dawson J.E., Katavolos P., Warner C.K., Kolbert C.P., Persing D.H. Perpetuation of the agent of human granulocytic ehrlichiosis in a deer tick-rodent cycle. Proc. Natl. Acad. Sci. USA. 93:1996;6209-6214.
42. Lovrich S.D., Callister S.M., Lim L.C., DuChateau B.K., Schell R.F. Seroprotective groups of Lyme borreliosis spirochetes from North America and Europe. J. Infect. Dis. 170:1994;115-121.
43. Zhong W., Stehle T., Museteanu C., Siebers A., Gern L., Kramer M., Wallich R., Simon M.M. Therapeutic passive vaccination against chronic Lyme disease in mice. Proc. Natl. Acad. Sci. USA. 94:1997;12533-12538.
44. Gilmore R.D. Jr, Kappel K.J., Dolan M.C., Burkot T.R., Johnson B.J. Outer surface protein C (OspC), but not P39, is a protective immunogen against a tick-transmitted Borrelia burgdorferi challenge: evidence for a conformational protective epitope in OspC. Infect. Immun. 64:1996;2234-2239.
45. Preac-Mursic V., Wilske B., Patsouris E., Jauris S., Will G., Soutschek E., Rainhardt S., Lehnert G., Klockmann U., Mehraein P. Active immunization with pC protein of Borrelia burgdorferi protects gerbils against B. burgdorferi infection. Infection. 20:1992;342-349.
46. Probert W.S., Crawford M., Cadiz R.B., LeFebvre R.B. Immunization with outer surface protein (Osp) A, but not OspC, provides cross-protection of mice challenged with North American isolates of Borrelia burgdorferi. J. Infect. Dis. 175:1997;400-405.
47. Hanson M.S., Cassatt D.R., Guo B.P., Patel N.K., McCarthy M.P., Dorward D.W., Hook M. Active and passive immunity against Borrelia burgdorferi decorin binding protein A (DbpA) protects against infection. Infect. Immun. 66:1998;2143-2153.
48. Cassatt D.R., Patel N.K., Ulbrandt N.D., Hanson M.S. DbpA, but not OspA, is expressed by Borrelia burgdorferi during spirochetemia and is a target for protective antibodies. Infect. Immun. 66:1998;5379-5387.
49. Hagman K.E., Lahdenne P., Popova T.G., Porcella S.F., Akins D.R., Radolf J.D., Norgard M.V. Decorin-binding protein of Borrelia burgdorferi is encoded within a two-gene operon and is protective in the murine model of Lyme borreliosis. Infect. Immun. 66:1998;2674-2683.
50. Gross DM, Forsthuber T, Tary-Lehmann M, Etling C, Ito K, Nagy ZA, Field JA, Steere AC, Hubert BT. Identification of LFA-1 as a candidate autoantigen in treatment-resistant Lyme arthritis. Science 1998;281:703.